18 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Chiasma Competitors or Alternatives

Chiasma's top competitors include Renova Therapeutics, Axsome and Auspex Pharmaceuticals.

Unlock 14 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Chiasma's company profile

Raj Kannan

CEO

- -
18
$265.8M
$7.7M
  • $265.8M
    $7.7M
  • 18
    $265.8M
  • $7.7M
  • - -
  • 18
  • $265.8M
  • $7.7M
View ProfileView
1
Chiasma's Competitor - Renova Therapeutics logo

Vijay Mahant

CEO

82/100
25 - 100
$7.5M
$100K - 5M
  • $7.5M
    $100K - 5M
  • 25 - 100
    $7.5M
  • $100K - 5M
  • 82/100
  • 25 - 100
  • $7.5M
  • $100K - 5M
View ProfileView
2
Chiasma's Competitor - Axsome logo

Herriot Tabuteau

Chairman & CEO

89/100
380
$829.7M
$385.7M
  • $829.7M
    $385.7M
  • 380
    $829.7M
  • $385.7M
  • 89/100
  • 380
  • $829.7M
  • $385.7M
View ProfileView
3
Chiasma's Competitor - Auspex Pharmaceuticals logo

CEO

- -
25 - 100
$181.3M
$5M - 25M
  • $181.3M
    $5M - 25M
  • 25 - 100
    $181.3M
  • $5M - 25M
  • - -
  • 25 - 100
  • $181.3M
  • $5M - 25M
View ProfileView
4
Chiasma's Competitor - bluebird bio logo

Andrew Obenshain

CEO

73/100
520
$821.4M
$83.8M
  • $821.4M
    $83.8M
  • 520
    $821.4M
  • $83.8M
  • 73/100
  • 520
  • $821.4M
  • $83.8M
View ProfileView
5
Chiasma's Competitor - Lysogene logo

Karen Pignet-Aiach

Chairman & CEO

90/100
22
$82.9M
$16.4M
  • $82.9M
    $16.4M
  • 22
    $82.9M
  • $16.4M
  • 90/100
  • 22
  • $82.9M
  • $16.4M
View ProfileView
Chiasma's top 17 competitors are Renova Therapeutics, Axsome, Auspex Pharmaceuticals, uniQure, bluebird bio, Lysogene, Intra-Cellular, Strongbridge Biopharma, Flexion, Concert, Sage Therapeutics, Voyager, Thar Pharmaceuticals, SCYNEXIS, Neurona Therapeutics, Transition Therapeutics and Minerva Neurosciences. Together they have raised over 6.6B between their estimated 3.1K employees. Chiasma has 18 employees and is ranked 16th among it's top 10 competitors. The top 10 competitors average 173.

Chiasma VS Renova Therapeutics

Renova Therapeutics has been one of Chiasma's top competitors. Renova Therapeutics's headquarters is in San Diego, California, and was founded in 2009. Like Chiasma, Renova Therapeutics also competes in the Biotechnology field. Renova Therapeutics generates 62% of Chiasma's revenue.

Chiasma VS Axsome

Axsome is one of Chiasma's top rivals. Axsome is a Public company that was founded in New York, New York in 2012. Like Chiasma, Axsome also works within the Biotechnology industry. Axsome has 362 more employees vs. Chiasma.

Chiasma VS Auspex Pharmaceuticals

Auspex Pharmaceuticals is perceived as one of Chiasma's biggest rivals. Auspex Pharmaceuticals was founded in 2001, and is headquartered in La Jolla, California. Like Chiasma, Auspex Pharmaceuticals also competes in the Biotechnology sector. Auspex Pharmaceuticals generates $2.7M less revenue vs. Chiasma.

Looking for similar companies to Chiasma?

Similar Companies

Biotechnology companies in Waltham

See 97 companies 
Companies in Waltham with revenue in $5.0-25M range

See 891 companies 
Pharmaceuticals & Biotechnology companies in Waltham

See 121 companies 
Companies in Waltham with employees in 25-100 range

See 1,200 companies 
Biotechnology companies in Greater Boston

See 1,266 companies 
Biotechnology companies in Massachusetts

See 1,343 companies 
Pharmaceuticals & Biotechnology companies in Greater Boston

See 1,622 companies 
Pharmaceuticals & Biotechnology companies in Massachusetts

See 1,717 companies 
Biotechnology companies with revenue in $5.0-25M range

See 3,620 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Chiasma and Chiasma's Competitors

April 1, 2025GlobalNewswire
Results support continued development in MDD with concomitant EDS; Phase 3 trial planned in 2025...
March 31, 2025Benzinga
- Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and li...
March 31, 2025Benzinga
Bluebird Bio Inc. (NASDAQ: BLUE) shares are trading higher Monday after the company received an unsolicited takeover offer from Ayrmid Ltd. read more...

Frequently Asked Questions about Chiasma

  1. Who are Chiasma's top competitors?

    Chiasma's top 3 competitors are Renova Therapeutics, Axsome, Auspex Pharmaceuticals.

  2. Who is similar to Chiasma?

    Renova Therapeutics is the most similar to Chiasma. Axsome and Auspex Pharmaceuticals are also similar to Chiasma.

  1. Are Chiasma and Renova Therapeutics competitors?

    Yes, Renova Therapeutics is one of Chiasma’s top competitors.